Assessment of potential drug and substance interference on the performance of the CNOGA TensorTip blood glucose measuring device
- Conditions
- diabetesNutritional, Metabolic, Endocrine
- Registration Number
- ISRCTN67040922
- Lead Sponsor
- CNOGA Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 10
1. Healthy subjects verified by safety chemistry and blood count
2. Able to complete and understand informed consent form (by him/herself or by his/her guardian)
3. 18 years old and above
4. No constant treatment with medication
5. Safety biochemistry and blood count with exclusively values in normal range
1. Severe life-threatening disease
2. Anatomical conditions that may hamper good contact between the device and the measured finger, at the discretion of the investigator
3. Pregnancy
4. Nursing mothers
5. Healthy volunteers with a hypersensitivity to any of the tested interferents
6. History of alcoholism (anamnestic exclusion)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method